In addition, no association between higher sHLA-G levels and clinicopathological features has been observed in hepatocellular carcinoma (33), colorectal cancer (77), gastric cancer (47), esophageal carcinoma (50, 51), and renal cell carcinoma (62). The gene discussed is HLA-G; the disease is hereditary clear cell renal cell carcinoma.